Shareholders of Valeant Pharmaceuticals International Inc. are finally giving the drugmaker a chance, at least until next quarter.
The stock jumped 25 percent Tuesday to close at $28.16, after the company stuck with the full-year guidance it gave in June. Chief executive officer Joe Papa promised to renegotiate terms with lenders, said the company could sell about $8 billion worth of assets, and announced a strategic reorganiza...
19:34 CEO shift at Coca-Cola could usher in more dealmaking to refresh soda giant's growth15
14:34 Coca-Cola Elevating Operating Chief to CEO, Succeeding Kent15
18:07 Trump Said to Pick Fast-Food CEO Puzder as Labor Secretary12
14:14 Lego Group CEO Knudstorp to head new Lego branding division18